These data collectively disclose the novel mechanism of NLRP3 inflammasome activation and microgliosis in AD and related Tauopathies which is directly mediated by NLRP3 acetylation induced by pathological Tau proteins. This evidence concerns the gene MAPT and Alzheimer disease.